3Sixty Public Affairs and PDCI Market Access have collaborated to create an infographic that unmasks the reality behind the assumptions Health Canada has used to justify its ongoing drug pricing reforms (through the Patented Medicine Prices Review Board). When it comes to federal drug pricing reform in Canada, there is much more “below the surface” than what Health Canada is letting on.

See the full infographic in English and French.

Please contact Kaitlyn Proulx, Managing Director at PDCI at kaitlyn.proulx@pdci.ca for any questions or further information.